Condition: Endometrial Cancer · Sponsor: Leiden University Medical Center
The RAINBO umbrella program consists of four clinical trials investigating new adjuvant therapies in endometrial cancer patients. Eligible patients will be assigned to one of the four RAINBO trials based on the molecular profile of their cancer: * p53 abnormal endometrial cancer patients to the p53abn-RED trial * mismatch repair deficient endometrial cancer patients to the MMRd-GREEN trial * no specific molecular profile endometrial cancer patients to NSMP-ORANGE trial * POLE mutant endometrial cancer patients to the POLEmut-BLUE trial
This description comes directly from the study's public registry record.
Carien L Creutzberg, MD PhD · +31 71 52 65539 · c.l.creutzberg@lumc.nl
Nanda Horeweg, MD PhD · +31 71 52 65539 · n.horeweg@lumc.nl
Always discuss trial participation with your own doctor first.
| The POLEmut-BLUE trial: Princess Margaret Cancer Centre, University of Toronto | Toronto, Canada | Recruiting |
| The POLEmut-BLUE trial: University of British Columbia | Vancouver, Canada | Recruiting |
| The p53abn-RED trial: Institute Gustave Roussy | Villejuif, France | Not Yet Recruiting |
| Amsterdam University Medical Center | Amsterdam, Netherlands | Recruiting |
| Amphia Ziekenhuis | Breda, Netherlands | Recruiting |
| Instituut Verbeeten | Breda, Netherlands | Recruiting |
| Catharina Ziekenhuis | Eindhoven, Netherlands | Recruiting |
| Medisch Spectrum Twente | Enschede, Netherlands | Recruiting |
| Universitair Medisch Centrum Groningen | Groningen, Netherlands | Recruiting |
| The MMRd-GREEN trial: Leiden University Medical Center | Leiden, Netherlands | Recruiting |
| Erasmus Medical Center | Rotterdam, Netherlands | Recruiting |
| Haags Medisch Centrum | The Hague, Netherlands | Recruiting |
+ 2 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05255653